UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors

Molecular therapy. Methods & clinical development, 2019-09, Vol.14, p.126-133

2019

Volltextzugriff (PDF)

Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients

Blood, 2013-02, Vol.121 (6), p.1039-1048

2013

Volltextzugriff (PDF)

Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans

Blood, 2015-02, Vol.125 (7), p.1180-1188

2015

Volltextzugriff (PDF)

Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A

Blood advances, 2024-06, Vol.8 (11), p.2726-2739

2024

Volltextzugriff (PDF)

The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?

Pharmaceutical research, 2016-09, Vol.33 (9), p.2239-2249

2016

Volltextzugriff (PDF)

Polyethylene glycol 20 kDa-induced vacuolation does not impair phagocytic function of human monocyte-derived macrophages

Frontiers in immunology, 2022-07, Vol.13, p.894411-894411

2022

Volltextzugriff (PDF)

Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-03, Vol.25 (2), p.e126-e129

2019

Volltextzugriff (PDF)

Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys

The Journal of pharmacology and experimental therapeutics, 2019-10, Vol.371 (1), p.95-105

2019

Volltextzugriff (PDF)

Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive In Vitro Assays

Human gene therapy. Part B. Methods, 2019-04, Vol.30 (2), p.35-43

2019

Volltextzugriff (PDF)

Divergent Light-, Ascorbate-, and Oxidative Stress-Dependent Regulation of Expression of the Peroxiredoxin Gene Family in Arabidopsis

Plant physiology (Bethesda), 2003-01, Vol.131 (1), p.317-325

2003

Volltextzugriff (PDF)

The plant-specific function of 2-Cys peroxiredoxin-mediated detoxification of peroxides in the redox-hierarchy of photosynthetic electron flux

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (8), p.5738-5743

2002

Volltextzugriff (PDF)

Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia B

International journal of hematology, 2013-11, Vol.98 (5), p.525-532

2013

Volltextzugriff (PDF)

A false sense of security? Can tiered approach be trusted to accurately classify immunogenicity samples?

Journal of pharmaceutical and biomedical analysis, 2016-09, Vol.128, p.166-173

2016

Volltextzugriff (PDF)

Redox-regulation of the expression of the peroxide-detoxifying chloroplast 2-Cys peroxiredoxin in the liverwort Riccia fluitans

Planta, 2001-12, Vol.214 (2), p.304-313

2001

Volltextzugriff (PDF)

Immunogenicity of BAX 855 in Previously Treated Patients with Congenital Severe Hemophilia Α

Blood, 2016-12, Vol.128 (22), p.2594-2594

2016

Volltextzugriff (PDF)

The Effect of Inhibitory Antibodies on Acute Treatment of Bleeding Episodes with OΒΙ-1, an Antihemophilic Factor VIII (recombinant), Porcine Sequence, in Patients with Acquired Hemophilia Α

Blood, 2014-12, Vol.124 (21), p.2831-2831

2014

Volltextzugriff (PDF)

A comparison of methods for classifying samples as truly specific with confirmatory immunoassays

Journal of pharmaceutical and biomedical analysis, 2014-01, Vol.88, p.27-35

2014

Volltextzugriff (PDF)

A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassays

Journal of pharmaceutical and biomedical analysis, 2011-07, Vol.55 (5), p.1148-1156

2011

Volltextzugriff (PDF)

Preclinical Immunogenicity Assessment of Baxter‘s Recombinant Factor VIIa

Blood, 2011-11, Vol.118 (21), p.3327-3327

2011

Volltextzugriff (PDF)

Preclinical Immunogenicity Assessment of Baxter‘s Longer-Acting FVIII Candidate BAX 855 Using Novel Preclinical Models

Blood, 2011-11, Vol.118 (21), p.3323-3323

2011

Volltextzugriff (PDF)

Type II peroxiredoxin C, a member of the peroxiredoxin family of Arabidopsis thaliana: its expression and activity in comparison with other peroxiredoxins

Plant physiology and biochemistry, 2002-06, Vol.40 (6), p.491-499

2002

Volltextzugriff (PDF)

Preclinical Safety of Baxter's Recombinant Factor IX

Blood, 2010-11, Vol.116 (21), p.4654-4654

2010

Volltextzugriff (PDF)

Preclinical Safety of Baxter's Recombinant Factor VIIa

Blood, 2010-11, Vol.116 (21), p.1417-1417

2010

Volltextzugriff (PDF)

Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes

Expert review of clinical pharmacology, 2015-03, Vol.8 (2), p.163-177

2015

Volltextzugriff (PDF)

Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

Blood, 2011-11, Vol.118 (21), p.2275-2275

2011

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(19)
Humans
(11)
Hematology
(6)
Male
(6)
Pharmacology & Pharmacy
(6)
Adult
(5)
Animals
(5)
Biological And Medical Sciences
(5)
Enzyme-Linked Immunosorbent Assay
(5)
Antibodies, Neutralizing - Immunology
(4)
Chemistry
(4)
Enzymes
(4)
Female
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)
Hemophilia A - Immunology
(4)
Physical Sciences
(4)
Young Adult
(4)
Adolescent
(3)
Anti-Drug Antibody
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors

Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients

Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans

Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A

The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?

Polyethylene glycol 20 kDa-induced vacuolation does not impair phagocytic function of human monocyte-derived macrophages

Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B

Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys

Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive In Vitro Assays

Divergent Light-, Ascorbate-, and Oxidative Stress-Dependent Regulation of Expression of the Peroxiredoxin Gene Family in Arabidopsis

The plant-specific function of 2-Cys peroxiredoxin-mediated detoxification of peroxides in the redox-hierarchy of photosynthetic electron flux

Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia B

A false sense of security? Can tiered approach be trusted to accurately classify immunogenicity samples?

Redox-regulation of the expression of the peroxide-detoxifying chloroplast 2-Cys peroxiredoxin in the liverwort Riccia fluitans

Immunogenicity of BAX 855 in Previously Treated Patients with Congenital Severe Hemophilia Α

The Effect of Inhibitory Antibodies on Acute Treatment of Bleeding Episodes with OΒΙ-1, an Antihemophilic Factor VIII (recombinant), Porcine Sequence, in Patients with Acquired Hemophilia Α

A comparison of methods for classifying samples as truly specific with confirmatory immunoassays

A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassays

Preclinical Immunogenicity Assessment of Baxter‘s Recombinant Factor VIIa

Preclinical Immunogenicity Assessment of Baxter‘s Longer-Acting FVIII Candidate BAX 855 Using Novel Preclinical Models

Type II peroxiredoxin C, a member of the peroxiredoxin family of Arabidopsis thaliana: its expression and activity in comparison with other peroxiredoxins

Preclinical Safety of Baxter's Recombinant Factor IX

Preclinical Safety of Baxter's Recombinant Factor VIIa

Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes

Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

Suchergebnisse filtern